weimar sepsis update 2009
Technical realization of the online Lectures was sponsored
by
Presentations
For the Author`s scientific profile at BIOMEDEXPERTS, please click author
Why sepsis goes public
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena,
Key Note Lecture: Sepsis as main cause of death in children
Department of Pediatrics, University of British Columbia,
Hot Topics
Why we need the CHEST trial on the safety and efficacy of HES 130/04
Department of Intensive Care Medicine, The George Institute for International Health
Sydney, Australia
ICU patients with A/H1N1 influenca – experiences and unsolved problems
University of Manitoba, Health Sciences Centre, St. Boniface Hospital,Winnipeg, Manitoba, USA
Nosocomial infections – an interdisciplinary challenge
Prevention of multiresistant bacteria – the Dutch experience
Julius Center for Health Sciences and Primary Care, UMC Utrecht,
Prevention of sepsis
SDD versus SOD – when and how
Julius Center for Health Sciences and Primary Care, UMC Utrecht,
Update and controversies on adjunctive therapies of sepsis
Update on corticosteroids
Department of Anesthesiology and Critical Care Medicine, Hadassah University Hospital Ein-Karem, Jerusalem, Israel
Anticoagulatory strategies – an update
Division of Infectious Diseases, The Memorial Hospital of Rhode Island,
Selenium
Department of Medicine, Kingston General Hospital,
To follow the lectures of the Lunchsymposium:
Selenium in Intensive Care from an International Point of View
sponsored by biosyn Arzneimittel GmbH, please contact Ms. Julia Staiger at biosyn
Does early administration of selenium improve neurological
outcome after cardiac arrest?
Johann Reisinger, Austria
The possible role of selenium in the peri-operative period
Zsolt Molnár, Hungary
The first experience of using selenase in patients with long-term
unconscious stage
Ruslan Nazarov, Russia
Adjunctive therapy of sepsis – new promising therapeutic targets
Immunomodulatory therapy of sepsis
Critical Care Division, Washington University School of Medicine,
Immunglobulins in sepsis – how strong is the evidence
Universitätsklinik und Poliklinik für Innere Medizin III, Klinikum der MLU Halle-Wittenberg,
Anti-Toll-like receptor strategies
Institut für Mikrobiologie und Hygiene, Charité – Universitätsmedizin Berlin,
Rational use of antimicrobials in sepsis
Indications for new generation antifungals
Klinik für Hämatologie und Onkologie, Ernst-von-Bergmann-Klinikum,
How can we bring evidence based medicine to the bedside
Pitfalls in the applicazion of clinical trial results
Critical Care Medicine Department, National Institutes of Health,
How and why sepsis bundles reduce mortality
Section of Critical Care Medicine, Cooper University Hospital, Camden, USA
Impact of sepsis bundles in Spain
A. Artigas Raventós
Medicina Intensiva, Corporació Sanitària Parc Taulí,
New insights in the pathophysiology of sepsis
Why sepsis patients die – mechanism of organ failure
Critical Care Division, Washington University School of Medicine,
Prevention and treatment of organ dysfunction
Modulation of perfusion and oxygenation
Fachübergreifende Klinik für operative Intensivmedizin Erwachsene,
Universitätsklinikum Aachen,
Volume replacement
Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Helios-Klinikum Erfurt GmbH
Lung injury
Office of Research, Vanderbilt University School of Medicine
Respiratory therapy in ALI
Dipartimento Terapia Intensiva, Università degli Studi di Milano
Drug therapy in ALI
Klinik für Innere Medizin II, Universitätsklinikum Giessen, Giessen, Germany
Liver failure
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
Renal replacement therapy
S. John
Medizinische Klinik 4, Universitätsklinikum Leipzig
Metabolic control of sepsis
Prevention and treatment of metabolic failure
Pulmonary and Critical Care Medicine, The George Washington University Medical Center,
Lessons from the NICE SUGAR trial
Department of Medicine, Kingston General Hospital,
Tight glucose control – what remains for daily clinical practice
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
Jena, Germany
Clinical benefit of new and known sepsis markers
Risk assessment and progression markers
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
Jena, Germany
Procalcitonin for antibiotic stewardship
B. Müller
Klinik für Allgemeine Innere Medizin, Kantonsspital Aarau
Start Presentation
Transcriptomic signatures in SIRS and sepsis
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
Printer-friendly version
